The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro
Anticancer Research · 2024
DOI: 10.21873/anticanres.17142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von David Zekan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, West Virginia University School of Medicine, Morgantown, WV, U.S.A.; dszekan@hsc.wvu.edu. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carboplatin.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, West Virginia University School of Medicine, Morgantown, WV, U.S.A.; dszekan@hsc.wvu.edu.
- Section of Hematology and Oncology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV, U.S.A.
- Department of Urology, West Virginia University School of Medicine, Morgantown, WV, U.S.A.
Zitieren
APA
Zekan, D., Hogan, T., Jackson, B., Jackson, G., & Kandzari, S. (2024). The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro. Anticancer Research. https://doi.org/10.21873/anticanres.17142
Vancouver
Zekan D, Hogan T, Jackson B, Jackson G, Kandzari S. The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro. Anticancer Research. 2024. doi:10.21873/anticanres.17142
BibTeX
@article{Zekan2024,
author = {Zekan, David and Hogan, Thomas and Jackson, Barbara and Jackson, Garrett and Kandzari, Stanley},
title = {The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17142}
}
EUVIMED